FDA PMA FDA Class 3 Approved 🇺🇸 United States

Prosthesis, Intervertebral Disc

PMA: P090029 · Supplement: S003 · Decision Jul 7, 2016
Classifications
1
FEI Numbers
73
Registration Numbers
73

Basic Information

Device Name
Prosthesis, Intervertebral Disc
Trade Name
PRESTIGE LP(TM) CERVICAL DISC
PMA Number
P090029
Supplement Number
S003
Device Class
FDA Class 3
Product Code
MJO
Generic Name
Prosthesis, intervertebral disc
Medical Specialty
Unknown
Advisory Committee
Orthopedic
Decision
Approved
Decision Code
APPR
Decision Date
July 7, 2016
Date Received
June 3, 2015
Supplement Type
Panel Track
Supplement Reason
Labeling Change - Indications/instructions/shelf life/tradename
Expedited Review
N
Docket Number
16M-2182

Advisory Committee Statement

Approval for the Prestige LP Cervical Disc. This device is indicated in skeletally mature patients for reconstruction of the disc from C3-C7 following discectomy at one level or two contiguous levels for intractable radiculopathy (arm pain and/or a neurological deficit) with or without neck pain, or myelopathy due to abnormality localized to the level of the disc space and at least one of the following conditions confirmed by imaging (CT, MRI, X-rays): herniated nucleus pulposus, spondylosis (defined by the presence of osteophytes), and/or visible loss of disc height as compared to adjacent levels. The PRESTIGE LP™ Cervical Disc is implanted using an anterior approach. Patients should have failed at least 6 weeks of non-operative treatment or have had the presence of progressive symptoms or signs of nerve root/spinal cord compression in the face of continued non-operative management prior to implantation of the PRESTIGE LP Cervical Disc.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MJO Prosthesis, Intervertebral Disc